Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1990 Jun;58(6):1861–1869. doi: 10.1128/iai.58.6.1861-1869.1990

Cytotoxic activity of the Proteus hemolysin HpmA.

K G Swihart 1, R A Welch 1
PMCID: PMC258736  PMID: 2341182

Abstract

We previously showed that hpmA is the hemolysin determinant most commonly found among Proteus isolates. To assess the potential contribution of HpmA to virulence, we first characterized the toxic activities of this hemolysin. Hemolytic activity was present in total cell cultures and cell-free supernatants of Proteus clinical isolates as well as Escherichia coli containing cloned hpm genes. HpmA also possesses cytotoxic activity which was detected by a chromium release assay against a variety of target cell lines (Daudi, Raji, T24, U937, and Vero). Analysis of the dose response of bacterial cells against both T24 cells and erythrocytes showed that E. coli containing cloned hpm genes was 30-fold more cytotoxic than Proteus mirabilis BA6163. Also, 10(5)-fold more bacterial cells were needed to lyse T24 cells than to lyse erythrocytes. HpmA- mutants of two Proteus strains in which the central portion of hpmA was deleted were constructed. These HpmA- mutants, which have lost the hemolytic and cytotoxic activities exhibited by their respective parent strains, demonstrate that HpmA is needed for both of these activities. In an ascending model of murine urinary tract infection, the hpmA mutant strain WPM111 behaved no differently from its parent strain, BA6163, with respect to either the level of kidney colonization or histopathological changes in the kidney. However, WPM111 had a sixfold higher 50% lethal dose than BA6163 when injected intravenously into C3H mice.

Full text

PDF
1861

Images in this article

1866Image
on p.1866

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRAUDE A. I., SIEMIENSKI J. Role of bacterial urease in experimental pyelonephritis. J Bacteriol. 1960 Aug;80:171–179. doi: 10.1128/jb.80.2.171-179.1960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bauernfeind A., Naber K., Sauerwein D. Spectrum of bacterial pathogens in uncomplicated and complicated urinary tract infections. Eur Urol. 1987;13 (Suppl 1):9–12. doi: 10.1159/000472851. [DOI] [PubMed] [Google Scholar]
  3. Braun V., Neuss B., Ruan Y., Schiebel E., Schöffler H., Jander G. Identification of the Serratia marcescens hemolysin determinant by cloning into Escherichia coli. J Bacteriol. 1987 May;169(5):2113–2120. doi: 10.1128/jb.169.5.2113-2120.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cavalieri S. J., Snyder I. S. Cytotoxic activity of partially purified Escherichia coli alpha haemolysin. J Med Microbiol. 1982 Feb;15(1):11–21. doi: 10.1099/00222615-15-1-11. [DOI] [PubMed] [Google Scholar]
  5. Cavalieri S. J., Snyder I. S. Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte function in vitro. Infect Immun. 1982 Sep;37(3):966–974. doi: 10.1128/iai.37.3.966-974.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cavalieri S. J., Snyder I. S. Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte viability in vitro. Infect Immun. 1982 May;36(2):455–461. doi: 10.1128/iai.36.2.455-461.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Felmlee T., Pellett S., Welch R. A. Nucleotide sequence of an Escherichia coli chromosomal hemolysin. J Bacteriol. 1985 Jul;163(1):94–105. doi: 10.1128/jb.163.1.94-105.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gadeberg O. V., Orskov I. In vitro cytotoxic effect of alpha-hemolytic Escherichia coli on human blood granulocytes. Infect Immun. 1984 Jul;45(1):255–260. doi: 10.1128/iai.45.1.255-260.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Griffith D. P., Musher D. M., Itin C. Urease. The primary cause of infection-induced urinary stones. Invest Urol. 1976 Mar;13(5):346–350. [PubMed] [Google Scholar]
  10. Gross-Weege W., König W., Scheffer J., Nimmich W. Induction of histamine release from rat mast cells and human basophilic granulocytes by clinical Escherichia coli isolates and relation to hemolysin production and adhesin expression. J Clin Microbiol. 1988 Sep;26(9):1831–1837. doi: 10.1128/jcm.26.9.1831-1837.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hacker J., Hof H., Emödy L., Goebel W. Influence of cloned Escherichia coli hemolysin genes, S-fimbriae and serum resistance on pathogenicity in different animal models. Microb Pathog. 1986 Dec;1(6):533–547. doi: 10.1016/0882-4010(86)90039-2. [DOI] [PubMed] [Google Scholar]
  12. Hagberg L., Engberg I., Freter R., Lam J., Olling S., Svanborg Edén C. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun. 1983 Apr;40(1):273–283. doi: 10.1128/iai.40.1.273-283.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Holmgren K., Danielson B. G., Fellström B. Infection-induced urinary calculi and renal failure. Scand J Urol Nephrol. 1987;21(3):219–223. doi: 10.3109/00365598709180325. [DOI] [PubMed] [Google Scholar]
  14. Keane W. F., Welch R., Gekker G., Peterson P. K. Mechanism of Escherichia coli alpha-hemolysin-induced injury to isolated renal tubular cells. Am J Pathol. 1987 Feb;126(2):350–357. [PMC free article] [PubMed] [Google Scholar]
  15. Kopp R., Müller J., Lemme R. Inhibition of Swarming of Proteus by Sodium Tetradecyl Sulfate, beta-Phenethyl Alcohol, and p-Nitrophenylglycerine. Appl Microbiol. 1966 Nov;14(6):873–878. doi: 10.1128/am.14.6.873-878.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Koronakis V., Cross M., Senior B., Koronakis E., Hughes C. The secreted hemolysins of Proteus mirabilis, Proteus vulgaris, and Morganella morganii are genetically related to each other and to the alpha-hemolysin of Escherichia coli. J Bacteriol. 1987 Apr;169(4):1509–1515. doi: 10.1128/jb.169.4.1509-1515.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Koronakis V., Hughes C. Identification of the promoters directing in vivo expression of hemolysin genes in Proteus vulgaris and Escherichia coli. Mol Gen Genet. 1988 Jul;213(1):99–104. doi: 10.1007/BF00333404. [DOI] [PubMed] [Google Scholar]
  18. Koronakis V., Koronakis E., Hughes C. Comparison of the haemolysin secretion protein HlyB from Proteus vulgaris and Escherichia coli; site-directed mutagenesis causing impairment of export function. Mol Gen Genet. 1988 Aug;213(2-3):551–555. doi: 10.1007/BF00339631. [DOI] [PubMed] [Google Scholar]
  19. König W., Faltin Y., Scheffer J., Schöffler H., Braun V. Role of cell-bound hemolysin as a pathogenicity factor for Serratia infections. Infect Immun. 1987 Nov;55(11):2554–2561. doi: 10.1128/iai.55.11.2554-2561.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Marre R., Hacker J., Henkel W., Goebel W. Contribution of cloned virulence factors from uropathogenic Escherichia coli strains to nephropathogenicity in an experimental rat pyelonephritis model. Infect Immun. 1986 Dec;54(3):761–767. doi: 10.1128/iai.54.3.761-767.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. McLean R. J., Nickel J. C., Noakes V. C., Costerton J. W. An in vitro ultrastructural study of infectious kidney stone genesis. Infect Immun. 1985 Sep;49(3):805–811. doi: 10.1128/iai.49.3.805-811.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Miller V. L., Mekalanos J. J. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol. 1988 Jun;170(6):2575–2583. doi: 10.1128/jb.170.6.2575-2583.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Oka A., Sugisaki H., Takanami M. Nucleotide sequence of the kanamycin resistance transposon Tn903. J Mol Biol. 1981 Apr 5;147(2):217–226. doi: 10.1016/0022-2836(81)90438-1. [DOI] [PubMed] [Google Scholar]
  24. Peerbooms P. G., Verweij A. M., MacLaren D. M. Investigation of the haemolytic activity of Proteus mirabilis strains. Antonie Van Leeuwenhoek. 1983 Apr;49(1):1–11. doi: 10.1007/BF00457874. [DOI] [PubMed] [Google Scholar]
  25. Peerbooms P. G., Verweij A. M., MacLaren D. M. Uropathogenic properties of Proteus mirabilis and Proteus vulgaris. J Med Microbiol. 1985 Feb;19(1):55–60. doi: 10.1099/00222615-19-1-55. [DOI] [PubMed] [Google Scholar]
  26. Peerbooms P. G., Verweij A. M., MacLaren D. M. Vero cell invasiveness of Proteus mirabilis. Infect Immun. 1984 Mar;43(3):1068–1071. doi: 10.1128/iai.43.3.1068-1071.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pellett S., Boehm D. F., Snyder I. S., Rowe G., Welch R. A. Characterization of monoclonal antibodies against the Escherichia coli hemolysin. Infect Immun. 1990 Mar;58(3):822–827. doi: 10.1128/iai.58.3.822-827.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Pohlner J., Halter R., Beyreuther K., Meyer T. F. Gene structure and extracellular secretion of Neisseria gonorrhoeae IgA protease. 1987 Jan 29-Feb 4Nature. 325(6103):458–462. doi: 10.1038/325458a0. [DOI] [PubMed] [Google Scholar]
  29. Poole K., Schiebel E., Braun V. Molecular characterization of the hemolysin determinant of Serratia marcescens. J Bacteriol. 1988 Jul;170(7):3177–3188. doi: 10.1128/jb.170.7.3177-3188.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Scheffer J., König W., Hacker J., Goebel W. Bacterial adherence and hemolysin production from Escherichia coli induces histamine and leukotriene release from various cells. Infect Immun. 1985 Oct;50(1):271–278. doi: 10.1128/iai.50.1.271-278.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Schiebel E., Braun V. Integration of the Serratia marcescens haemolysin into human erythrocyte membranes. Mol Microbiol. 1989 Mar;3(3):445–453. doi: 10.1111/j.1365-2958.1989.tb00190.x. [DOI] [PubMed] [Google Scholar]
  32. Schiebel E., Schwarz H., Braun V. Subcellular location and unique secretion of the hemolysin of Serratia marcescens. J Biol Chem. 1989 Sep 25;264(27):16311–16320. [PubMed] [Google Scholar]
  33. Senior B. W., Albrechtsen M., Kerr M. A. Proteus mirabilis strains of diverse type have IgA protease activity. J Med Microbiol. 1987 Sep;24(2):175–180. doi: 10.1099/00222615-24-2-175. [DOI] [PubMed] [Google Scholar]
  34. Silverblatt F. J. Host-parasite interaction in the rat renal pelvis: a possible role for pili in the pathogenesis of pyelonephritis. J Exp Med. 1974 Dec 1;140(6):1696–1711. doi: 10.1084/jem.140.6.1696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Stamm W. E., Martin S. M., Bennett J. V. Epidemiology of nosocomial infection due to Gram-negative bacilli: aspects relevant to development and use of vaccines. J Infect Dis. 1977 Aug;136 (Suppl):S151–S160. doi: 10.1093/infdis/136.supplement.s151. [DOI] [PubMed] [Google Scholar]
  36. Swihart K. G., Welch R. A. The HpmA hemolysin is more common than HlyA among Proteus isolates. Infect Immun. 1990 Jun;58(6):1853–1860. doi: 10.1128/iai.58.6.1853-1860.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Uphoff T. S., Welch R. A. Nucleotide sequencing of the Proteus mirabilis calcium-independent hemolysin genes (hpmA and hpmB) reveals sequence similarity with the Serratia marcescens hemolysin genes (shlA and shlB). J Bacteriol. 1990 Mar;172(3):1206–1216. doi: 10.1128/jb.172.3.1206-1216.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Welch R. A., Dellinger E. P., Minshew B., Falkow S. Haemolysin contributes to virulence of extra-intestinal E. coli infections. Nature. 1981 Dec 17;294(5842):665–667. doi: 10.1038/294665a0. [DOI] [PubMed] [Google Scholar]
  39. Welch R. A. Identification of two different hemolysin determinants in uropathogenic Proteus isolates. Infect Immun. 1987 Sep;55(9):2183–2190. doi: 10.1128/iai.55.9.2183-2190.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Wray S. K., Hull S. I., Cook R. G., Barrish J., Hull R. A. Identification and characterization of a uroepithelial cell adhesin from a uropathogenic isolate of Proteus mirabilis. Infect Immun. 1986 Oct;54(1):43–49. doi: 10.1128/iai.54.1.43-49.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Yanagida N., Uozumi T., Beppu T. Specific excretion of Serratia marcescens protease through the outer membrane of Escherichia coli. J Bacteriol. 1986 Jun;166(3):937–944. doi: 10.1128/jb.166.3.937-944.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Zwadyk P., Jr, Snyder I. S. Purification and kinetic studies of the hemolysin from Escherichia coli. Can J Microbiol. 1971 Jun;17(6):741–745. doi: 10.1139/m71-118. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES